Literature DB >> 21523740

A review of Canadian health care and cancer care systems.

Simon B Sutcliffe1.   

Abstract

Canada is a westernized, market-economy nation with a publicly funded health care and cancer control system and has health indices reflective of a high-resource economy. Provision of health services is in accord with the Canada Health Act and is implemented through federal, provincial, and territorial relations wherein federal funding partly provides support for the provincial/territorial delivery of health services. Cancer services are provided within the acute health care system with dedicated entities existing in parallel in most provinces to provide services specific to the diagnosis, treatment, and support of cancer patients. Interprovincial and territorial collaboration to enhance and facilitate optimal cancer system performance is enabled through the Canadian Partnership Against Cancer (the Canadian national cancer control initiative). Adolescent and young adult (AYA) cancer patients use both the pediatric and adult cancer systems. There is recognition, however, that although AYA patients are numerically a small portion of all cancer patients, the negative personal, societal, and socioeconomic impacts of potential years of life lost are substantial and can be lessened through attention to awareness, education, redesign of care and care pathways, quality of life, developmental aspects related to adolescent-teen-adult transitions, continuity of care, and surveillance across pediatric and adult settings. Appropriate solutions need to be established within the framework of the Canadian Health Service by innovative rethinking and realignment of system capacity and performance to the special needs of AYA cancer patients.
© 2011 American Cancer Society

Entities:  

Mesh:

Year:  2011        PMID: 21523740     DOI: 10.1002/cncr.26053

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  Oncofertility in Canada: an overview of Canadian practice and suggested action plan.

Authors:  R Ronn; H E G Holzer
Journal:  Curr Oncol       Date:  2013-10       Impact factor: 3.677

2.  Do current cancer follow-up care practices meet the needs of young adult cancer survivors in Canada? A qualitative inquiry.

Authors:  B Miedema; J Easley; L M Robinson
Journal:  Curr Oncol       Date:  2013-02       Impact factor: 3.677

3.  Identifying clinical and support service resources and network practices for cancer patients and survivors in southern Puerto Rico.

Authors:  Eida M Castro; Julio C Jiménez; Gwendolyn Quinn; Myra García; Yesenia Colón; Axel Ramos; Thomas Brandon; Vani Simmons; Clement Gwede; Susan Vadaparampil; Cruz María Nazario
Journal:  Support Care Cancer       Date:  2014-09-24       Impact factor: 3.603

4.  Associated factors and costs of avoidable visits to the emergency department among cancer patients: 1-year experience in a tertiary care hospital in South Korea.

Authors:  Tak Kyu Oh; You Hwan Jo; Jae Wook Choi
Journal:  Support Care Cancer       Date:  2018-05-08       Impact factor: 3.603

5.  Real world costs and cost-effectiveness of Rituximab for diffuse large B-cell lymphoma patients: a population-based analysis.

Authors:  Sara Khor; Jaclyn Beca; Murray Krahn; David Hodgson; Linda Lee; Michael Crump; Karen E Bremner; Jin Luo; Muhammad Mamdani; Chaim M Bell; Carol Sawka; Scott Gavura; Terrence Sullivan; Maureen Trudeau; Stuart Peacock; Jeffrey S Hoch
Journal:  BMC Cancer       Date:  2014-08-12       Impact factor: 4.430

6.  Examination of Breast Cancer Screening Knowledge, Attitudes, and Beliefs among Syrian Refugee Women in a Western Canadian Province.

Authors:  Louise Racine; Isil Andsoy; Sithokozile Maposa; Hassanali Vatanparast; Susan Fowler-Kerry
Journal:  Can J Nurs Res       Date:  2021-05-26

7.  The Transformation of Adolescent and Young Adult Oncological and Supportive Care in Canada: A Mixed Methods Study.

Authors:  Jonathan Avery; Emily Wong; Christine Harris; Stacy Chapman; Serena Uppal; Shaayini Shanawaz; Annemarie Edwards; Laura Burnett; Tushar Vora; Abha A Gupta
Journal:  Curr Oncol       Date:  2022-07-20       Impact factor: 3.109

8.  Mapping Canadian Data Assets to Generate Real-World Evidence: Lessons Learned from Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration's RWE Data Working Group.

Authors:  Wei Fang Dai; Claire de Oliveira; Scott Blommaert; Reka E Pataky; David Tran; Zeb Aurangzeb; Cynthia Kendell; Chris Folkins; Chandy Somayaji; Jeff Dowden; Winson Cheung; Erin Strumpf; Jaclyn M Beca; Carol McClure; Robin Urquhart; James Ted McDonald; Riaz Alvi; Donna Turner; Stuart Peacock; Avram Denburg; Rebecca E Mercer; Caroline Muñoz; Ambica Parmar; Mina Tadrous; Pam Takhar; Kelvin K W Chan
Journal:  Curr Oncol       Date:  2022-03-17       Impact factor: 3.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.